Bellerophon Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Bellerophon Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q2 2023.
  • Bellerophon Therapeutics, Inc. Operating Lease, Payments for the quarter ending June 30, 2023 was $8K, a 95.9% decline year-over-year.
  • Bellerophon Therapeutics, Inc. Operating Lease, Payments for the twelve months ending June 30, 2023 was $599K, a 22.8% decline year-over-year.
  • Bellerophon Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $783K, a 1.69% increase from 2021.
  • Bellerophon Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $770K, a 1.72% increase from 2020.
  • Bellerophon Therapeutics, Inc. annual Operating Lease, Payments for 2020 was $757K, a 10.8% increase from 2019.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $599K $8K -$188K -95.9% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $787K $197K +$4K +2.07% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $783K $197K +$3K +1.55% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 $780K $197K +$4K +2.07% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $776K $196K +$3K +1.55% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $773K $193K +$3K +1.58% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $770K $194K +$4K +2.11% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $766K $193K +$3K +1.58% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $763K $193K +$3K +1.58% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $760K $190K +$3K +1.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $757K $190K +$3K +1.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $754K $190K +$19K +11.1% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $735K $190K +$26K +15.9% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $709K $187K +$26K +16.1% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $683K $187K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $171K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $164K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $161K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.